Published in J Clin Invest on June 01, 1986
Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ (1991) 4.46
Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest (2006) 3.41
Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ (1988) 2.65
Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol (2012) 2.58
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol (2003) 2.21
Differences in kidney function and incident hypertension: the multi-ethnic study of atherosclerosis. Ann Intern Med (2008) 2.11
Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ (1988) 1.91
Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol (2006) 1.79
Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest (1995) 1.72
Role of aldosterone in the remnant kidney model in the rat. J Clin Invest (1996) 1.65
Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression. J Biol Chem (2008) 1.43
Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease. Am J Nephrol (2010) 1.33
Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest (1992) 1.28
Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest (1995) 1.27
Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure. BMJ (1994) 1.24
Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest (1990) 1.23
Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest (1999) 1.21
Antifibrotic effect of tamoxifen in a model of progressive renal disease. J Am Soc Nephrol (2011) 1.20
Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis. Am J Pathol (2002) 1.19
Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes. J Clin Invest (2001) 1.17
Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis. J Clin Invest (1988) 1.17
Remission of renal disease: recounting the challenge, acquiring the goal. J Clin Invest (2002) 1.14
Urinary angiotensinogen accurately reflects intrarenal Renin-Angiotensin system activity. Am J Nephrol (2010) 1.13
Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys. J Clin Invest (1995) 1.09
Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass. Proc Natl Acad Sci U S A (1988) 1.05
Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J Clin Invest (1988) 1.03
Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats. Clin Exp Nephrol (2009) 1.01
Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis. Am J Physiol Renal Physiol (2009) 0.98
A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome. Am J Pathol (1991) 0.97
Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy. Pediatr Nephrol (2008) 0.96
Glomerular sclerosis is prevented during urinary tract obstruction due to podocyte protection. Am J Physiol Renal Physiol (2010) 0.95
Glomerular hypertrophy aggravates epithelial cell injury in nephrotic rats. J Clin Invest (1990) 0.95
Spontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance. Am J Physiol Renal Physiol (2006) 0.94
Causes and pathogenesis of focal segmental glomerulosclerosis. Nat Rev Nephrol (2014) 0.94
Unrecognised high pressure chronic retention of urine presenting with systemic arterial hypertension. BMJ (1989) 0.93
Obesity and kidney protection. J Nephropathol (2014) 0.93
Renal outcome in adults with renal insufficiency and irregular asymmetric kidneys. BMC Nephrol (2004) 0.93
Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis. Hypertension (2011) 0.91
Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression. J Am Soc Nephrol (2013) 0.91
Renal protective effects of N-acetyl-Ser-Asp-Lys-Pro in deoxycorticosterone acetate-salt hypertensive mice. J Hypertens (2011) 0.90
The membrane attack complex, C5b-9, up regulates collagen gene expression in renal tubular epithelial cells. Clin Exp Immunol (2004) 0.89
Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice: role of endothelin-1. Am J Pathol (2001) 0.89
Hemodynamic correlates of proteinuria in chronic kidney disease. Clin J Am Soc Nephrol (2011) 0.88
Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both? Pediatr Nephrol (2004) 0.87
Nebivolol does not protect against 5/6 ablation/infarction induced chronic kidney disease in rats - comparison with angiotensin II receptor blockade. Life Sci (2012) 0.86
The glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans. Microsc Microanal (2012) 0.86
The molecular basis of increased glomerulosclerosis after blockade of the renin angiotensin system in growth hormone transgenic mice. Mol Med (1994) 0.86
Proposal for mapping renal failure in Japan and its application for strategy to arrest endstage renal disease. Clin Exp Nephrol (2006) 0.85
Suramin alleviates glomerular injury and inflammation in the remnant kidney. PLoS One (2012) 0.85
Cellular mechanisms mediating rat renal microvascular constriction by angiotensin II. J Clin Invest (1997) 0.85
An evaluation of experimental models of glomerulonephritis. Int J Exp Pathol (1994) 0.84
Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease. Int J Clin Med (2011) 0.84
Application of direct renin inhibition to chronic kidney disease. Cardiovasc Drugs Ther (2010) 0.84
Factors associated with a vicious cycle involving a low nephron number, hypertension and chronic kidney disease. Hypertens Res (2015) 0.83
Regression of albuminuria and hypertension and arrest of severe renal injury by a losartan-hydrochlorothiazide association in a model of very advanced nephropathy. PLoS One (2013) 0.82
Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation. J Clin Invest (1987) 0.81
Diabetes, dietary protein and glomerular hyperfiltration. West J Med (1987) 0.80
Sodium-glucose linked transporter-2 inhibitors in chronic kidney disease. ScientificWorldJournal (2015) 0.79
Sodium-Glucose Linked Cotransporter-2 Inhibition Does Not Attenuate Disease Progression in the Rat Remnant Kidney Model of Chronic Kidney Disease. PLoS One (2016) 0.78
The Gordon Wilson lecture. Why kidneys fail: an unifying hypothesis. Trans Am Clin Climatol Assoc (1987) 0.78
Time course and localization of endothelin-1 gene expression in a model of renal disease progression. Am J Pathol (1997) 0.78
Blasts from the past. J Clin Invest (2004) 0.78
TGFβ receptor I transactivation mediates stretch-induced Pak1 activation and CTGF upregulation in mesangial cells. J Cell Sci (2013) 0.78
Effect of Shenkang granules on the progression of chronic renal failure in 5/6 nephrectomized rats. Exp Ther Med (2015) 0.78
Relationship between GFR and albuminuria in stage 1 hypertension. Clin J Am Soc Nephrol (2012) 0.77
Repetitive mechanical strain suppresses macrophage uptake of immunoglobulin G complexes and enhances cyclic adenosine monophosphate synthesis. Am J Pathol (1995) 0.77
When to initiate ACEI/ARB therapy in patients with type 1 and 2 diabetes. Pediatr Nephrol (2010) 0.77
Transient Exposure of Enalapril Normalizes Prenatal Programming of Hypertension and Urinary Angiotensinogen Excretion. PLoS One (2015) 0.77
Aspects of the role of intraglomerular pressure as a cause of progressive renal damage. Drugs (1988) 0.76
Effects of enalapril on renal parameters in patients with primary glomerulopathies associated with chronic renal failure. Drugs (1990) 0.76
Dose-dependent effects of angiotensin converting enzyme (ACE) inhibitors on glomerular prostanoid production by normotensive rats. Br J Pharmacol (1993) 0.76
Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome. Pediatr Nephrol (2012) 0.76
Renoprotective effects of direct renin inhibition in glomerulonephritis. Am J Med Sci (2014) 0.76
Effect of angiotensin converting enzyme inhibitor on collagen production by cultured mesangial cells. Korean J Intern Med (1994) 0.75
Selective inhibition of platelet thromboxane generation with low-dose aspirin does not protect rats with reduced renal mass from the development of progressive disease. Am J Pathol (1989) 0.75
Need kidneys fail? West J Med (1986) 0.75
Transient enalapril attenuates the reduction in glomerular filtration rate in prenatally programmed rats. Physiol Rep (2017) 0.75
Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment. J Am Soc Nephrol (2017) 0.75
First International Symposium on Cilazapril Preclinical and Clinical Pharmacology. Lausanne, switzerland, May 5-7, 1988. Proceedings. Br J Clin Pharmacol (1989) 0.75
Prevention of renoprival nephropathy. West J Med (1986) 0.75
Interaction of the renin angiotensin and cox systems in the kidney. Front Biosci (Schol Ed) (2016) 0.75
Altered renal kallikrein and renin gene expression in nephrotic rats and modulation by converting enzyme inhibition. J Clin Invest (1993) 0.75
Glomerular Function and Structure in Living Donors: Lessons from Single Nephron Studies. Curr Transplant Rep (2016) 0.75
Olmesartan attenuates tacrolimus-induced biochemical and ultrastructural changes in rat kidney tissue. Biomed Res Int (2014) 0.75
Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy. Am J Physiol Renal Physiol (2015) 0.75
Nephrology, dialysis and transplantation. Postgrad Med J (1990) 0.75
ACE inhibitors in non-diabetic renal disease. Br Heart J (1994) 0.75
Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk. J Am Soc Nephrol (2017) 0.75
Perindopril safety and tolerance in at-risk patients. Drugs (1990) 0.75
Glomerular function reserve and sodium sensitivity. Clin Exp Nephrol (2005) 0.75
Angiotensin-converting enzyme inhibitors in chronic renal failure. Drugs (1990) 0.75
Systemic and regional haemodynamic profile of diuretics and alpha- and beta-blockers. A review comparing acute and chronic effects. Drugs (1988) 0.75
Nephroprotective effect of ACE inhibitors. Drugs (1993) 0.75
Does significant renal ablation truly and invariably lead to hyperfiltration and progressive chronic kidney disease? Clin Exp Nephrol (2016) 0.75
Effects of ACE inhibition on renal haemodynamics in essential hypertension and hypertension associated with chronic renal failure. Drugs (1991) 0.75
Renal protective effect of long term antihypertensive therapy with enalapril. Drugs (1988) 0.75
Some statistical methods useful in circulation research. Circ Res (1980) 11.88
[A simple colorimetric method of inulin determination in renal clearance studies on metabolically normal subjects and diabetics]. Klin Wochenschr (1955) 5.62
Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol (1981) 4.75
Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest (1985) 2.99
Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest (1986) 2.96
Dynamics of glomerular ultrafiltration in the rat. IV. Determination of the ultrafiltration coefficient. J Clin Invest (1973) 2.55
Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat. J Clin Invest (1976) 2.47
Effects of surgery on plasma volume and salt and water excretion in rats. Am J Physiol (1977) 1.96
Determination of serum protein concentration in nanoliter blood samples using fluorescamine or 9-phthalaldehyde. Anal Biochem (1978) 1.89
Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A (1985) 1.85
Pathogenesis of the glomerulopathy associated with renal infarction in rats. Kidney Int (1976) 1.77
Dynamics of glomerular ultrafiltration in the rat. VII. Response to reduced renal mass. Am J Physiol (1974) 1.62
Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J Clin Invest (1984) 1.55
Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med (1971) 1.51
Functional adaptation to reduction in renal mass. Physiol Rev (1979) 1.48
Renal and nephron hemodynamics in spontaneously hypertensive rats. Am J Physiol (1979) 1.17
Glomerular adaptations to chronic dietary salt restriction or excess. Am J Physiol (1980) 1.13
Renin- and non-renin-mediated antihypertensive actions of converting enzyme inhibitors. Kidney Int (1984) 1.13
Diabetic nephropathy and arterial hypertension. The effect of antihypertensive treatment. Diabetes (1983) 1.12
Therapeutic implications of hypertension-induced glomerular injury. Comparison of enalapril and a combination of hydralazine, reserpine, and hydrochlorothiazide in an experimental model. Am J Med (1985) 1.08
Comparison of the antihypertensive and hormonal effects of a cardioselective beta-blocker, acebutolol, and diuretics in essential hypertension. Am J Med (1978) 1.05
Regulation of glomerular capillary pressure and filtration rate in young Kyoto hypertensive rats. Clin Sci (Lond) (1979) 1.04
Effects of glomerular filtration dynamics on the glomerular permeability coefficient. Am J Physiol (1981) 1.03
Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man. N Engl J Med (1975) 1.02
Amelioration of experimental glomerulonephritis by dietary protein restriction. Kidney Int (1983) 1.01
Long-term antihypertensive treatment (over six years) inhibiting the progression of diabetic nephropathy. Acta Endocrinol Suppl (Copenh) (1981) 0.99
Influence of hypertension on the progression of experimental autologous immune complex nephritis. J Lab Clin Med (1983) 0.97
Progression of renal failure in patients with renal disease of diverse etiology on protein-restricted diet. Kidney Int (1985) 0.95
Glomerular injury in uninephrectomized spontaneously hypertensive rats. A consequence of glomerular capillary hypertension. J Clin Invest (1986) 0.94
Single-nephron dynamics in "post-salt" rats with chronic hypertension. J Lab Clin Med (1978) 0.89
Effects of blood pressure control on the progression of renal insufficiency in chronic renal failure. Panminerva Med (1984) 0.88
Nephrotoxic serum nephritis with hypertension: amelioration by antihypertensive therapy. Kidney Int (1985) 0.86
Sequence and organization of the human mitochondrial genome. Nature (1981) 57.39
Complete sequence of bovine mitochondrial DNA. Conserved features of the mammalian mitochondrial genome. J Mol Biol (1982) 11.71
Shotgun DNA sequencing using cloned DNase I-generated fragments. Nucleic Acids Res (1981) 8.23
Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet (2000) 7.16
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med (2001) 6.22
Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst (1999) 5.92
Determinants and consequences of smoke-free homes: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control (2006) 5.63
Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med (1995) 5.45
Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med (1995) 5.27
A short primer for sequencing DNA cloned in the single-stranded phage vector M13mp2. Nucleic Acids Res (1980) 4.98
Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest (1997) 4.83
Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol (1981) 4.75
Distinctive sequence of human mitochondrial ribosomal RNA genes. Nature (1980) 4.30
Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens (1988) 3.86
A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med (1989) 3.83
Different pattern of codon recognition by mammalian mitochondrial tRNAs. Proc Natl Acad Sci U S A (1980) 3.74
The relationship between peritubular capillary protein concentration and fluid reabsorption by the renal proximal tubule. J Clin Invest (1969) 3.39
The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med (1982) 3.13
Complete mitochondrial genome sequences of two extinct moas clarify ratite evolution. Nature (2001) 3.12
Prescribing at the hospital-general practice interface. I: Hospital outpatient dispensing policies in England. BMJ (1992) 3.09
Effects of the 2003 advertising/promotion ban in the United Kingdom on awareness of tobacco marketing: findings from the International Tobacco Control (ITC) Four Country Survey. Tob Control (2006) 3.05
Role of molecular charge in glomerular permeability. Tracer studies with cationized ferritins. J Cell Biol (1975) 3.04
Counselling in general practice. J R Coll Gen Pract (1979) 2.99
Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest (1985) 2.99
Implication of a novel multiprotein Dam1p complex in outer kinetochore function. J Cell Biol (2001) 2.98
Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest (1986) 2.96
A mutant of Arabidopsis deficient in the chloroplast 16:1/18:1 desaturase. Plant Physiol (1989) 2.93
Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening. Sex Transm Infect (2004) 2.92
Pathogenesis of polycation-induced alterations ("fusion") of glomerular epithelium. Lab Invest (1977) 2.82
Genetic Bit Analysis: a solid phase method for typing single nucleotide polymorphisms. Nucleic Acids Res (1994) 2.79
Involvement of DNA polymerase alpha in simian virus 40 DNA replication. J Biol Chem (1978) 2.74
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials. Lancet (2015) 2.70
Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet (1991) 2.70
Impaired development of Th2 cells in IL-13-deficient mice. Immunity (1998) 2.68
Nephron adaptation to renal injury or ablation. Am J Physiol (1985) 2.65
Molecular basis of proteinuria of glomerular origin. N Engl J Med (1978) 2.61
Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon. J Exp Med (1988) 2.61
Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc Natl Acad Sci U S A (1991) 2.55
Dynamics of glomerular ultrafiltration in the rat. IV. Determination of the ultrafiltration coefficient. J Clin Invest (1973) 2.55
Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med (1991) 2.46
Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet (1999) 2.42
Should we adjust for covariates in nonlinear regression analyses of randomized trials? Control Clin Trials (1998) 2.40
High-level production of uniformly ¹⁵N- and ¹³C-enriched fusion proteins in Escherichia coli. J Biomol NMR (1996) 2.38
Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int (1981) 2.36
Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. Diabetologia (2010) 2.35
A model of glomerular ultrafiltration in the rat. Am J Physiol (1972) 2.32
The dynamics of glomerular ultrafiltration in the rat. J Clin Invest (1971) 2.27
The relationship between glomerular filtration rate and sodium reabsorption by the proximal tubule of the rat nephron. J Clin Invest (1968) 2.27
Dynamics of glomerular ultrafiltration in the rat. II. Plasma-flow dependence of GFR. Am J Physiol (1972) 2.24
Collapsing glomerulopathy in HIV and non-HIV patients: a clinicopathological and follow-up study. Kidney Int (1999) 2.20
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. N Engl J Med (2015) 2.18
Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice. Blood (2000) 2.16
Primary structure and functional expression of a cDNA encoding the thiazide-sensitive, electroneutral sodium-chloride cotransporter. Proc Natl Acad Sci U S A (1993) 2.15
Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes. J Natl Cancer Inst (2001) 2.12
The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia. Nat Genet (1999) 2.02
Effects of some vasodilator drugs on transcapillary fluid exchange in renal cortex. Am J Physiol (1976) 2.01
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology (2010) 2.01
Influence of postglomerular hematocrit and protein concentration on rat nephron fluid transfer. Am J Physiol (1971) 1.97
Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest (1991) 1.96
Isolation of a genomic clone for bovine pancreatic trypsin inhibitor by using a unique-sequence synthetic DNA probe. Proc Natl Acad Sci U S A (1983) 1.96
Cell migration from the ganglionic eminences is required for the development of hippocampal GABAergic interneurons. Neuron (2000) 1.91
Determination of serum protein concentration in nanoliter blood samples using fluorescamine or 9-phthalaldehyde. Anal Biochem (1978) 1.89
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23. J Clin Oncol (2001) 1.87
Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int (1982) 1.86
Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent. J Virol (1989) 1.86
Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Adjuvant Breast and Bowel Project. World J Surg (1994) 1.86
Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A (1985) 1.85
Identification and localization of polycystin, the PKD1 gene product. J Clin Invest (1996) 1.84
Permselectivity of the glomerular capillary wall: III. Restricted transport of polyanions. Kidney Int (1975) 1.83
Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. Mol Psychiatry (2001) 1.81
Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. Kidney Int (2006) 1.80
Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res (1994) 1.77
An olfactory sensory map develops in the absence of normal projection neurons or GABAergic interneurons. Neuron (1998) 1.76
Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int (2000) 1.74
Relationship between extracellular volume and fluid reabsorption by the rat nephron. Am J Physiol (1969) 1.74
Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab Invest (1989) 1.73
ROMK inwardly rectifying ATP-sensitive K+ channel. II. Cloning and distribution of alternative forms. Am J Physiol (1995) 1.72
Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminants. Cancer (1993) 1.70
Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCR. Cancer Res (2001) 1.69
Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res (1975) 1.69
Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int (1983) 1.65
An inhibitory effect of furosemide on sodium reabsorption by the proximal tubule of the rat nephron. J Clin Invest (1969) 1.65
Permselectivity of the glomerular capillary wall to macromolecules. II. Experimental studies in rats using neutral dextran. Biophys J (1975) 1.64
Dynamics of glomerular ultrafiltration in the rat. 3. Hemodynamics and autoregulation. Am J Physiol (1972) 1.63
Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. J Clin Invest (1992) 1.63
Dynamics of glomerular ultrafiltration in the rat. VII. Response to reduced renal mass. Am J Physiol (1974) 1.62
Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat. Kidney Int (1981) 1.62
Metabolism of Okazaki fragments during simian virus 40 DNA replication. J Biol Chem (1979) 1.62